Literature DB >> 31020695

Hyperthermic intraperitoneal chemotherapy with oxaliplatin-Still not the standard of care for patients with colorectal peritoneal metastases.

Alexander Julianov1, Azize Saroglu1.   

Abstract

Entities:  

Keywords:  cancer; chemotherapy; evidence-based medicine

Mesh：

Substances：

Year:  2019        PMID： 31020695      PMCID： PMC6624398          DOI： 10.1111/bcp.13926

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  4 in total

1.  Hyperthermic intraperitoneal chemotherapy with oxaliplatin-Still not the standard of care for patients with colorectal peritoneal metastases.

Authors:  Alexander Julianov; Azize Saroglu
Journal:  Br J Clin Pharmacol       Date:  2019-04-25       Impact factor: 4.335

Review 2.  Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis: a clinical pharmacological perspective on a surgical procedure.

Authors:  Loek A W de Jong; Fortuné M K Elekonawo; Philip R de Reuver; Andre J A Bremers; Johannes H W de Wilt; Frank G A Jansman; Rob Ter Heine; Nielka P van Erp
Journal:  Br J Clin Pharmacol       Date:  2018-10-25       Impact factor: 4.335

3.  Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.

Authors:  Vic J Verwaal; Serge van Ruth; Eeclo de Bree; Gooike W van Sloothen; Harm van Tinteren; Henk Boot; Frans A N Zoetmulder
Journal:  J Clin Oncol       Date:  2003-10-15       Impact factor: 44.544

4.  A Multicenter Randomized Trial to Evaluate Hematologic Toxicities after Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin or Mitomycin in Patients with Appendiceal Tumors.

Authors:  Edward A Levine; Konstantinos I Votanopoulos; Perry Shen; Greg Russell; Joyce Fenstermaker; Paul Mansfield; David Bartlett; John H Stewart
Journal:  J Am Coll Surg       Date:  2018-01-10       Impact factor: 6.113
  4 in total
  2 in total

1.  Reply to 'Hyperthermic intraperitoneal chemotherapy with oxaliplatin-Still not standard of care for patients with colorectal peritoneal metastases' by Julianov and Saroglu.

Authors:  Loek A W de Jong; Nielka P van Erp
Journal:  Br J Clin Pharmacol       Date:  2019-06-22       Impact factor: 4.335

2.  Hyperthermic intraperitoneal chemotherapy with oxaliplatin-Still not the standard of care for patients with colorectal peritoneal metastases.

Authors:  Alexander Julianov; Azize Saroglu
Journal:  Br J Clin Pharmacol       Date:  2019-04-25       Impact factor: 4.335
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.